表紙
市場調查報告書

生化防禦 (生物武器防衛)的全球市場

Biodefense

出版商 Global Industry Analysts, Inc. 商品編碼 912539
出版日期 內容資訊 英文 92 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
生化防禦 (生物武器防衛)的全球市場 Biodefense
出版日期: 2019年10月01日內容資訊: 英文 92 Pages
簡介

本報告提供全球生化防禦 (生物武器防衛) 市場調查,提供市場概要,各產品·各地區的市場佔有率,需求趨勢,銷售額的變化與預測,市場成長要素,競爭情形,主要企業的簡介等全面性資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 競爭企業的市場佔有率
    • 競爭企業的市場佔有率:方案
  • 關注企業
  • 市場趨勢和成長要素
  • 全球市場預測
    • 市場估計·預測:各區各國
    • 市場方案:各區各國
    • 市場佔有率的轉變:各地區
    • 各產品
      • 疫苗
      • 生物性威脅檢測設備

第3章 市場分析

  • 地區市場分析
  • 美國
    • 市場概要
    • 市場佔有率:各企業
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲各國
  • 亞太地區
  • 其他 (RoW)

第4章 競爭情形

  • ACHAOGEN ,INC.
  • ALNYLAM PHARMACEUTICALS
  • ALTIMMUNE
  • ANP TECHNOLOGIES , INC.
  • BAVARIAN NORDIC A/S
  • CLEVELAND BIOLABS , INC.
  • ELUSYS THERAPEUTICS, INC.
  • EMERGENT BIOSOLUTIONS
  • ICHOR MEDICAL SYSTEMS, INC.
  • NEW HORIZONS DIAGNOSTIC CORPORATION
  • PATHSENSORS, INC.
  • RESEARCH INTERNATIONAL , INC.
  • SIGA TECHNOLOGIES

第5章 調查資料

目錄
Product Code: MCP-1831

Biodefense market worldwide is projected to grow by US$7 Billion, driven by a compounded growth of 6.5%. Vaccines, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.7%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$12.5 Billion by the year 2025, Vaccines will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 7.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$322.3 Million to the region's size and clout in the next 5 to 6 years. Over US$325.5 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Vaccines will reach a market size of US$960.7 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6.2% over the next couple of years and add approximately US$1.2 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, Achaogen, Inc.; Alexeter Technologies, LLC; Alnylam Pharmaceuticals, Inc.; Altimmune, Inc.; ANP Technologies, Inc.; Bavarian Nordic A/S; Cleveland BioLabs, Inc.; Elusys Therapeutics, Inc.; Emergent BioSolutions, Inc.; Ichor Medical Systems, Inc.; New Horizons Diagnostic Corporation; PathSensors, Inc.; Research International, Inc.; SIGA Technologies

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Biodefense Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Biodefense Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Biodefense Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Biodefense Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Vaccines (Product) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Vaccines (Product) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Vaccines (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Biothreat Detection Devices (Product) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Biothreat Detection Devices (Product) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Biothreat Detection Devices (Product) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Biodefense Market Share (in %) by Company: 2019 & 2025
    • TABLE 10: United States Biodefense Market Estimates and Projections in US$ Million by Product: 2018 to 2025
    • TABLE 11: Biodefense Market in the United States by Product: A Historic Review in US$ Million for 2009-2017
    • TABLE 12: United States Biodefense Market Share Breakdown by Product: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 13: Canadian Biodefense Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025
    • TABLE 14: Canadian Biodefense Historic Market Review by Product in US$ Million: 2009-2017
    • TABLE 15: Biodefense Market in Canada: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025
  • JAPAN
    • TABLE 16: Japanese Market for Biodefense: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025
    • TABLE 17: Biodefense Market in Japan: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017
    • TABLE 18: Japanese Biodefense Market Share Analysis by Product: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 19: Chinese Biodefense Market Growth Prospects in US$ Million by Product for the Period 2018-2025
    • TABLE 20: Biodefense Historic Market Analysis in China in US$ Million by Product: 2009-2017
    • TABLE 21: Chinese Biodefense Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Biodefense Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 22: European Biodefense Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 23: Biodefense Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 24: European Biodefense Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 25: European Biodefense Market Estimates and Forecasts in US$ Million by Product: 2018-2025
    • TABLE 26: Biodefense Market in Europe in US$ Million by Product: A Historic Review for the Period 2009-2017
    • TABLE 27: European Biodefense Market Share Breakdown by Product: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 28: Biodefense Market in France by Product: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 29: French Biodefense Historic Market Scenario in US$ Million by Product: 2009-2017
    • TABLE 30: French Biodefense Market Share Analysis by Product: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 31: Biodefense Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025
    • TABLE 32: German Biodefense Historic Market Analysis in US$ Million by Product: 2009-2017
    • TABLE 33: German Biodefense Market Share Breakdown by Product: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 34: Italian Biodefense Market Growth Prospects in US$ Million by Product for the Period 2018-2025
    • TABLE 35: Biodefense Historic Market Analysis in Italy in US$ Million by Product: 2009-2017
    • TABLE 36: Italian Biodefense Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 37: United Kingdom Market for Biodefense: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025
    • TABLE 38: Biodefense Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017
    • TABLE 39: United Kingdom Biodefense Market Share Analysis by Product: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 40: Rest of Europe Biodefense Market Estimates and Forecasts in US$ Million by Product: 2018-2025
    • TABLE 41: Biodefense Market in Rest of Europe in US$ Million by Product: A Historic Review for the Period 2009-2017
    • TABLE 42: Rest of Europe Biodefense Market Share Breakdown by Product: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 43: Biodefense Market in Asia-Pacific by Product: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 44: Asia-Pacific Biodefense Historic Market Scenario in US$ Million by Product: 2009-2017
    • TABLE 45: Asia-Pacific Biodefense Market Share Analysis by Product: 2009 VS 2019 VS 2025
  • REST OF WORLD
    • TABLE 46: Rest of World Biodefense Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025
    • TABLE 47: Rest of World Biodefense Historic Market Review by Product in US$ Million: 2009-2017
    • TABLE 48: Biodefense Market in Rest of World: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025

IV. COMPETITION

  • ACHAOGEN ,INC.
  • ALNYLAM PHARMACEUTICALS
  • ALTIMMUNE
  • ANP TECHNOLOGIES , INC.
  • BAVARIAN NORDIC A/S
  • CLEVELAND BIOLABS , INC.
  • ELUSYS THERAPEUTICS, INC.
  • EMERGENT BIOSOLUTIONS
  • ICHOR MEDICAL SYSTEMS, INC.
  • NEW HORIZONS DIAGNOSTIC CORPORATION
  • PATHSENSORS, INC.
  • RESEARCH INTERNATIONAL , INC.
  • SIGA TECHNOLOGIES

V. CURATED RESEARCH

Back to Top